| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.51e-05 | 5 | 43 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.62e-04 | 9 | 43 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.62e-04 | 9 | 43 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 2.02e-04 | 10 | 43 | 2 | GO:0016176 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 2.95e-04 | 12 | 43 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.05e-04 | 14 | 43 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 8.40e-04 | 20 | 43 | 2 | GO:0050664 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 1.18e-05 | 22 | 42 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 2.98e-05 | 299 | 42 | 6 | GO:0032409 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 4.03e-05 | 5 | 42 | 2 | GO:0070946 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 4.03e-05 | 5 | 42 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 4.91e-05 | 35 | 42 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 6.58e-05 | 107 | 42 | 4 | GO:0032411 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron maturation | 8.45e-05 | 7 | 42 | 2 | GO:0014042 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 8.45e-05 | 7 | 42 | 2 | GO:0070947 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 8.45e-05 | 7 | 42 | 2 | GO:0006742 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.49e-04 | 400 | 42 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.53e-04 | 133 | 42 | 4 | GO:0006939 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 1.66e-04 | 256 | 42 | 5 | GO:0032412 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 1.98e-04 | 266 | 42 | 5 | GO:0022898 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 1.98e-04 | 266 | 42 | 5 | GO:0043270 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 2.20e-04 | 11 | 42 | 2 | GO:0060264 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 3.11e-04 | 13 | 42 | 2 | GO:0002536 | |
| GeneOntologyBiologicalProcess | positive regulation of cell maturation | 3.63e-04 | 14 | 42 | 2 | GO:1903431 | |
| GeneOntologyBiologicalProcess | medium-chain fatty acid metabolic process | 4.18e-04 | 15 | 42 | 2 | GO:0051791 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 4.77e-04 | 16 | 42 | 2 | GO:0070944 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 5.57e-04 | 79 | 42 | 3 | GO:0006940 | |
| GeneOntologyBiologicalProcess | regulation of neuron maturation | 6.07e-04 | 18 | 42 | 2 | GO:0014041 | |
| GeneOntologyBiologicalProcess | response to yeast | 6.07e-04 | 18 | 42 | 2 | GO:0001878 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 6.18e-04 | 192 | 42 | 4 | GO:0034767 | |
| GeneOntologyBiologicalProcess | regulation of system process | 6.39e-04 | 734 | 42 | 7 | GO:0044057 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 6.77e-04 | 19 | 42 | 2 | GO:0070943 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 7.47e-04 | 202 | 42 | 4 | GO:0006937 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 7.51e-04 | 20 | 42 | 2 | GO:0002679 | |
| GeneOntologyBiologicalProcess | muscle system process | 7.89e-04 | 547 | 42 | 6 | GO:0003012 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 8.29e-04 | 21 | 42 | 2 | GO:0070942 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 9.11e-04 | 22 | 42 | 2 | GO:1902514 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 9.11e-04 | 22 | 42 | 2 | GO:0050665 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 9.97e-04 | 23 | 42 | 2 | GO:0086012 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 9.97e-04 | 23 | 42 | 2 | GO:0061577 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 9.97e-04 | 23 | 42 | 2 | GO:0060263 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 1.01e-03 | 97 | 42 | 3 | GO:0032414 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transport | 1.01e-03 | 97 | 42 | 3 | GO:1901379 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 1.04e-03 | 577 | 42 | 6 | GO:0043269 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 1.14e-03 | 101 | 42 | 3 | GO:0002028 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 1.52e-03 | 417 | 42 | 5 | GO:0034765 | |
| GeneOntologyCellularComponent | ribbon synapse | 3.86e-05 | 32 | 43 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 6.17e-05 | 6 | 43 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.69e-04 | 12 | 43 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 6.19e-04 | 18 | 43 | 2 | GO:0043020 | |
| GeneOntologyCellularComponent | dendrite | 1.70e-03 | 858 | 43 | 7 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.72e-03 | 860 | 43 | 7 | GO:0097447 | |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 9.55e-06 | 18 | 33 | 3 | MP:0020947 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 8.06e-05 | 6 | 33 | 2 | MP:0003184 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 8.06e-05 | 6 | 33 | 2 | MP:0013254 | |
| MousePheno | liver abscess | 1.13e-04 | 7 | 33 | 2 | MP:0003332 | |
| MousePheno | abnormal inner hair cell synaptic ribbon morphology | 1.13e-04 | 7 | 33 | 2 | MP:0004562 | |
| MousePheno | impaired granulocyte bactericidal activity | 2.40e-04 | 10 | 33 | 2 | MP:0005074 | |
| MousePheno | abnormal susceptibility to Orthomyxoviridae infection | 2.74e-04 | 54 | 33 | 3 | MP:0020945 | |
| Domain | ARM-type_fold | 6.36e-03 | 339 | 41 | 4 | IPR016024 | |
| Domain | SH3 | 1.18e-02 | 216 | 41 | 3 | PS50002 | |
| Domain | SH3 | 1.18e-02 | 216 | 41 | 3 | SM00326 | |
| Domain | SH3_domain | 1.24e-02 | 220 | 41 | 3 | IPR001452 | |
| Domain | SH3_9 | 1.27e-02 | 78 | 41 | 2 | PF14604 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 26086043 | ||
| Pubmed | Altered Gap Junction Network Topography in Mouse Models for Human Hereditary Deafness. | 1.56e-06 | 2 | 44 | 2 | 33036242 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 28193694 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 4.69e-06 | 3 | 44 | 2 | 10678931 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 4.69e-06 | 3 | 44 | 2 | 27044504 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 4.69e-06 | 3 | 44 | 2 | 24358335 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10891396 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 25474113 | ||
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 4.69e-06 | 3 | 44 | 2 | 18787174 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 26209274 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 24873968 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 22184329 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 4.69e-06 | 3 | 44 | 2 | 11018074 | |
| Pubmed | [PPARγ signal transduction pathway in the foam cell formation induced by visfatin]. | 4.69e-06 | 3 | 44 | 2 | 20945045 | |
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 4.69e-06 | 3 | 44 | 2 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 4.69e-06 | 3 | 44 | 2 | 20142487 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 9116268 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 4.69e-06 | 3 | 44 | 2 | 21570954 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 4.69e-06 | 3 | 44 | 2 | 25565313 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 39357591 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 12958309 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 11435342 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 31118934 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 23482812 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 16041040 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10085000 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10987289 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 21435178 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 4.69e-06 | 3 | 44 | 2 | 18703411 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 29228045 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17307863 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 22155727 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 4.69e-06 | 3 | 44 | 2 | 27829407 | |
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 4.69e-06 | 3 | 44 | 2 | 24576409 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 22376231 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 4.69e-06 | 3 | 44 | 2 | 28274989 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 26645958 | ||
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 4.69e-06 | 3 | 44 | 2 | 12364355 | |
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 4.69e-06 | 3 | 44 | 2 | 24549323 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 34557202 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 28467721 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10670582 | ||
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 4.69e-06 | 3 | 44 | 2 | 20881184 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 4.69e-06 | 3 | 44 | 2 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 4.69e-06 | 3 | 44 | 2 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 4.69e-06 | 3 | 44 | 2 | 23328631 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 34572995 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17114280 | ||
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 4.69e-06 | 3 | 44 | 2 | 19168575 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 25989352 | ||
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 4.69e-06 | 3 | 44 | 2 | 19503084 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17404617 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17332431 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 36592568 | ||
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 4.69e-06 | 3 | 44 | 2 | 11156938 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 30504842 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10772875 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 27798190 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 20702812 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 4.69e-06 | 3 | 44 | 2 | 23965970 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 26455429 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 15513930 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 15626477 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 15033459 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 4.69e-06 | 3 | 44 | 2 | 19077231 | |
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 4.69e-06 | 3 | 44 | 2 | 20828610 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 20817944 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 22319452 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 16895801 | ||
| Pubmed | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. | 4.69e-06 | 3 | 44 | 2 | 20690191 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 16772302 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 32504071 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 16280459 | ||
| Pubmed | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. | 4.69e-06 | 3 | 44 | 2 | 18185592 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 36853827 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 23024271 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 21253614 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 25873172 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 15310853 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 31393787 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10725280 | ||
| Pubmed | Otoferlin is a multivalent calcium-sensitive scaffold linking SNAREs and calcium channels. | 4.69e-06 | 3 | 44 | 2 | 28696301 | |
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 4.69e-06 | 3 | 44 | 2 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 4.69e-06 | 3 | 44 | 2 | 25689796 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 14993144 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 4.69e-06 | 3 | 44 | 2 | 12031896 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 11249873 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 15936744 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17220182 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 25628043 | ||
| Pubmed | The p47phox mouse knock-out model of chronic granulomatous disease. | 4.69e-06 | 3 | 44 | 2 | 7650482 | |
| Pubmed | Disseminated trichosporonosis in a murine model of chronic granulomatous disease. | 4.69e-06 | 3 | 44 | 2 | 12868577 | |
| Pubmed | A synaptic F-actin network controls otoferlin-dependent exocytosis in auditory inner hair cells. | 4.69e-06 | 3 | 44 | 2 | 26568308 | |
| Cytoband | 12p13 | 1.74e-03 | 64 | 44 | 2 | 12p13 | |
| Cytoband | 11p11.2 | 2.91e-03 | 83 | 44 | 2 | 11p11.2 | |
| Cytoband | 7q11.23 | 3.95e-03 | 97 | 44 | 2 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q32 | 5.97e-03 | 120 | 44 | 2 | chr4q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p11 | 9.52e-03 | 153 | 44 | 2 | chr11p11 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.88e-04 | 26 | 29 | 2 | 253 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 4.24e-06 | 399 | 44 | 7 | M40939 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.15e-06 | 188 | 44 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.97e-05 | 180 | 44 | 4 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.44e-05 | 187 | 44 | 4 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 188 | 44 | 4 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 188 | 44 | 4 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.59e-05 | 189 | 44 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.59e-05 | 189 | 44 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.67e-05 | 190 | 44 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.67e-05 | 190 | 44 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.74e-05 | 191 | 44 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.82e-05 | 192 | 44 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.98e-05 | 194 | 44 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| Drug | YM-09730-5 | 1.16e-05 | 23 | 44 | 3 | CID000002296 | |
| Drug | Clorgyline | 1.77e-05 | 168 | 44 | 5 | ctd:D003010 | |
| Drug | NSC-686960 | 2.18e-05 | 4 | 44 | 2 | CID000192816 | |
| Drug | Nilvadipine | 3.64e-05 | 5 | 44 | 2 | DB06712 | |
| Drug | Nisoldipine | 3.64e-05 | 5 | 44 | 2 | DB00401 | |
| Drug | B 874-67 | 3.64e-05 | 5 | 44 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 3.64e-05 | 5 | 44 | 2 | CID000084253 | |
| Drug | nemadipine-A | 3.64e-05 | 5 | 44 | 2 | CID002856102 | |
| Drug | 1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | 3.86e-05 | 34 | 44 | 3 | ctd:C569670 | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; HL60; HG-U133A | 3.90e-05 | 198 | 44 | 5 | 1588_UP | |
| Drug | CPU-23 | 5.45e-05 | 6 | 44 | 2 | CID003036051 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 2.17e-05 | 5 | 44 | 2 | DOID:3265 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 1.42e-04 | 12 | 44 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Sinus Node Dysfunction (disorder) | 2.25e-04 | 15 | 44 | 2 | C0428908 | |
| Disease | Deaf Mutism | 4.06e-04 | 20 | 44 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 4.06e-04 | 20 | 44 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.06e-04 | 20 | 44 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.06e-04 | 20 | 44 | 2 | C0581883 | |
| Disease | Prelingual Deafness | 4.06e-04 | 20 | 44 | 2 | C0011052 | |
| Disease | Bilateral Deafness | 4.06e-04 | 20 | 44 | 2 | C3665473 | |
| Disease | Deafness | 6.38e-04 | 25 | 44 | 2 | C0011053 | |
| Disease | Beta blocking agent use measurement | 6.63e-04 | 114 | 44 | 3 | EFO_0009929 | |
| Disease | hypertension, COVID-19 | 7.45e-04 | 27 | 44 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | response to angiotensin receptor blocker | 9.21e-04 | 30 | 44 | 2 | EFO_0010735 | |
| Disease | pelvic organ prolapse | 1.10e-03 | 136 | 44 | 3 | EFO_0004710 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HDDFVMIDFKPAFSK | 441 | O75143 | |
| IFQDTKSFPMHFDEK | 346 | Q86YB8 | |
| VMVFHHFGKDFPKSE | 411 | P43155 | |
| GKFAPFEIKEHMVLA | 466 | Q13111 | |
| VHLMKFSPDGEFFAT | 171 | Q9Y485 | |
| PGMAISFEAKDFLHV | 136 | Q08289 | |
| FTAFLHPEEFEHMKE | 191 | Q15293 | |
| KPKGFAFITFMFPEH | 441 | Q9Y4C8 | |
| DFIMKLPHKFDTLVG | 511 | P08183 | |
| DMFPEEFDKTSFHKV | 971 | Q3T906 | |
| PEFMFSINDFKVLKH | 226 | Q8IUS5 | |
| EPDVHFSKKFLNVFM | 451 | Q9UQF2 | |
| DKKGHIIHIDFGFMF | 1966 | P42356 | |
| MATDFAPGFQKKFHE | 426 | O00410 | |
| FHKTLKEMFPIEAGA | 51 | A6NI72 | |
| FHKTLKEMFPIEAGA | 26 | A8MVU1 | |
| FSRFMTEPKGKEHDD | 681 | O60313 | |
| VFEMDPKSLTGHEFF | 26 | Q6TFL4 | |
| IHFPKDFLSVMLEKG | 81 | Q9Y2Q3 | |
| FFGDKTDFHPLMDQF | 1131 | Q5TEA3 | |
| MFDPGHFLDKSGNFK | 406 | P33260 | |
| KVTLHKDPMRHDFGF | 941 | Q9C0E4 | |
| GEFFKDLEAPMDETH | 116 | Q9P1V8 | |
| LMEFGGTPKHFAEAK | 156 | Q9NV23 | |
| VMDKDDPPRGHKFFF | 511 | Q9ULB4 | |
| ELFIGKMHKTCFFAD | 291 | Q01668 | |
| IEESGFFEMPKDSFH | 406 | P80192 | |
| FVFDFHVSPDVMFDK | 301 | Q9HC10 | |
| FHDAKFMADIDLDPG | 641 | P26639 | |
| MFKDGEPSGHKEFRE | 301 | Q9NYV8 | |
| LKPFFMKEVGSHFDD | 61 | P35610 | |
| GAKDDFMEIKSHVFF | 341 | O00141 | |
| PHTHNMDGFFIAKFK | 571 | P46087 | |
| FMDQHPEMDFSKAKF | 316 | Q9Y266 | |
| AMLHKDGIEFAFKEP | 971 | Q8N3U4 | |
| FVPLKKFDTGDGMFL | 26 | Q7Z5S9 | |
| FKPMGFEVSFLKFLE | 2586 | O60281 | |
| KDHGMVPFIKIFLDD | 566 | Q6ZS81 | |
| AMKLVTKHFPGEFGS | 626 | Q96JH7 | |
| HKMVTFKFDLDGDAP | 1211 | Q9Y3S1 | |
| ESQPKFGHFLEFMDE | 766 | Q6P2D8 | |
| PRMFKAFVSKSHPEF | 426 | Q92995 | |
| FCFPEMKKDIHHFEF | 101 | Q0VGE8 | |
| LFCKTFPFHFMFDKD | 281 | Q02108 |